Improving acceptance of COVID-19 rapid testing in Latinx communities
Enhancing SARS-Co-V-2 Rapid Testing Acceptance in Latinx Communities
['FUNDING_U01'] · UNIVERSITY OF OREGON · NIH-10617097
This study is working to make COVID-19 rapid testing more accepted in Latinx communities by using friendly health messages and support in both English and Spanish, helping to reduce stigma and improve trust around testing.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF OREGON (nih funded) |
| Locations | 1 site (EUGENE, UNITED STATES) |
| Trial ID | NIH-10617097 on ClinicalTrials.gov |
What this research studies
This project aims to enhance the acceptance of SARS-CoV-2 rapid testing among Latinx communities by implementing a culturally tailored health promotion intervention. It utilizes a behavioral self-affirming implementation intention (SAII) approach to improve health messaging and reduce stigma associated with testing. The intervention will be available in both English and Spanish, making it accessible to individuals regardless of their language proficiency. By addressing social determinants of health, such as discrimination and mistrust, the project seeks to improve health outcomes and increase testing rates.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from Latinx communities who may face barriers to COVID-19 testing due to discrimination or mistrust.
Not a fit: Patients who are not part of Latinx communities or those who do not face barriers to testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased acceptance of COVID-19 testing and improved health outcomes in Latinx communities.
How similar studies have performed: Previous phases of this project have shown success in implementing similar health promotion interventions in vulnerable populations.
Where this research is happening
EUGENE, UNITED STATES
- UNIVERSITY OF OREGON — EUGENE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DEGARMO, DAVID S. — UNIVERSITY OF OREGON
- Study coordinator: DEGARMO, DAVID S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.